StudyLancet review: cannabinoids in chronic non-cancer pain — updated evidence synthesisRegulatoryGermany: BfArM publishes updated guidance on medicinal cannabis prescribingStudyNEJM: CBD adjunctive therapy in treatment-resistant epilepsy — long-term follow-upRegulatoryTGA Australia releases revised Special Access Scheme statisticsBusinessTilray and Aphria file expanded EU-GMP medical cannabis distribution agreementsRegulatoryUK MHRA consults on unlicensed cannabis-based medicinal products frameworkStudyJAMA: cannabinoids in chemotherapy-induced nausea — systematic review updateBusinessCanopy Growth restructures European operations amid German market expansionRegulatorySwissmedic authorises additional medicinal cannabis product classificationsStudyIACM publishes 2026 international consensus on cannabinoid dosing in palliative careStudyLancet review: cannabinoids in chronic non-cancer pain — updated evidence synthesisRegulatoryGermany: BfArM publishes updated guidance on medicinal cannabis prescribingStudyNEJM: CBD adjunctive therapy in treatment-resistant epilepsy — long-term follow-upRegulatoryTGA Australia releases revised Special Access Scheme statisticsBusinessTilray and Aphria file expanded EU-GMP medical cannabis distribution agreementsRegulatoryUK MHRA consults on unlicensed cannabis-based medicinal products frameworkStudyJAMA: cannabinoids in chemotherapy-induced nausea — systematic review updateBusinessCanopy Growth restructures European operations amid German market expansionRegulatorySwissmedic authorises additional medicinal cannabis product classificationsStudyIACM publishes 2026 international consensus on cannabinoid dosing in palliative care
Institute for Cannabinoid Therapy emblem
Institute for Cannabinoid Therapy
Est. International Education
Courses
Masterclass

Advanced Masterclass · Pain Management

Premium live teaching with international pain specialists, complex case analysis and expert panel.

Duration
6 hours · live cohort
Instructor
International Expert Panel
Level
Masterclass
Enrolment
USD $750
Overview

This course is designed for healthcare professionals seeking a rigorous, evidence-based understanding of advanced masterclass · pain management. It combines contemporary science, clinical reasoning and international regulatory perspective.

Learning objectives
  • Formulate cannabinoid-based approaches within multimodal pain management.
  • Analyse complex clinical cases with international faculty.
  • Interpret emerging research and translate it into responsible practice.
Curriculum
  1. 01
    Session 1 · Complex clinical cases

    Live case-based discussion with expert panel.

  2. 02
    Session 2 · Emerging research

    Critical appraisal of the latest evidence.

  3. 03
    Session 3 · Regulatory updates

    International regulatory developments affecting practice.

Who should attend
Pain specialistsPalliative careGPs with special interestPharmacists
Frequently asked questions
Is this live or recorded?+

Delivered live with a limited cohort; recordings available for 60 days.

Prerequisites?+

Completion of the Foundations Program is strongly recommended.